3 days ago
ARQT
AnalystsSeamus FernandezSeamus Fernandez's Stock Forecasts
AnalystsSeamus Fernandez
Analyst Ranking
Top 2%
#73 out of 5346 analysts
Average Return
+65.68%
Win Rate
72%70 out of 97
Risk vs Reward
Poor
Good
Seamus Fernandez's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +1,088.30% | $18.63 | $221.38 | 2025-05-09 - 2026-01-06 | Strong Buy |
Cidara Therapeutics IncCDTX | +768.16% | $25.50 | $221.38 | 2025-05-16 - 2026-01-06 | Strong Buy |
Cidara Therapeutics IncCDTX | +673.26% | $13.50 | $104.39 | 2024-11-08 - 2025-11-07 | Strong Buy |
Mbx Biosciences IncMBX | +424.08% | $6.27 | $32.86 | 2025-04-10 - 2026-04-09 | Strong Buy |
Cidara Therapeutics IncCDTX | +372.63% | $46.84 | $221.38 | 2025-06-24 - 2026-01-06 | Strong Buy |
Seamus Fernandez Analyst Color
Get additional color on Seamus Fernandez's coverage of popular stocks
9 days ago
BMY
a month ago
AMLX
2 months ago
TENX
4 months ago
LLY
4 months ago
LLY
5 months ago
APGE
5 months ago
AMLX
5 months ago
TENX
5 months ago
RYTM
7 months ago
LLY
7 months ago
GPCR
7 months ago
MBX
8 months ago
TENX
8 months ago
RYTM
8 months ago
BMY
10 months ago
LLY
10 months ago
CDTX
a year ago
MBX
a year ago
AMLX
a year ago
CDTX
a year ago
CDTX
a year ago
CDTX
a year ago
LLY
2 years ago
APGE
Seamus Fernandez's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arcutis Biotherapeutics IncARQT | 2 | Strong Buy | $38.00 | +50.26% | Maintains | 3 days ago |
Bristol Myers Squibb CoBMY | 9 | Strong Buy | $75.00 | +15.88% | Maintains | 9 days ago |
Septerna IncSEPN | 1 | Strong Buy | $45.00 | +15.89% | Maintains | a month ago |
Amylyx Pharmaceuticals IncAMLX | 4 | Strong Buy | $40.00 | +75.28% | Maintains | a month ago |
Tenax Therapeutics IncTENX | 5 | Strong Buy | $40.00 | +197.62% | Maintains | 2 months ago |
Avalyn Pharma IncAVLN | 1 | Strong Buy | $80.00 | +135.85% | Initiates Coverage On | 2 months ago |
Eli Lilly & CoLLY | 18 | Strong Buy | $1,183.00 | -0.23% | Reiterates | 3 months ago |
Aclaris Therapeutics IncACRS | 2 | Strong Buy | $12.00 | +103.05% | Initiates Coverage On | 3 months ago |
Sagimet Biosciences IncSGMT | 2 | Strong Buy | $25.00 | +175.94% | Maintains | 3 months ago |
Generate Biomedicines IncGENB | 1 | Strong Buy | $30.00 | +109.06% | Initiates Coverage On | 5 months ago |
Apogee Therapeutics IncAPGE | 7 | Strong Buy | $160.00 | +18.66% | Maintains | 5 months ago |
Rhythm Pharmaceuticals IncRYTM | 4 | Strong Buy | $143.00 | +23.67% | Maintains | 5 months ago |
Vaxcyte IncPCVX | 5 | Strong Buy | $116.00 | +99.76% | Reiterates | 6 months ago |
Structure Therapeutics IncGPCR | 3 | Strong Buy | $140.00 | +163.46% | Maintains | 7 months ago |
Mbx Biosciences IncMBX | 5 | Strong Buy | $88.00 | +29.76% | Maintains | 7 months ago |
Inventiva SaIVA | 1 | Strong Buy | $11.00 | +129.17% | Maintains | 9 months ago |
Cidara Therapeutics IncCDTX | 5 | Strong Buy | $167.00 | -24.56% | Maintains | 10 months ago |
Metsera IncMTSR | 1 | Strong Buy | $56.00 | N/A | Initiates Coverage On | a year ago |
Merck & Co IncMRK | 9 | Strong Buy | $122.00 | N/A | Maintains | 2 years ago |
Icosavax IncICVX | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 3 years ago |
Hillevax IncHLVX | 2 | Strong Buy | $34.00 | N/A | Maintains | 3 years ago |
Verve Therapeutics IncVERV | 1 | Strong Buy | $55.00 | N/A | Maintains | 3 years ago |
Cymabay Therapeutics IncCBAY | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Arcturus Therapeutics Holdings IncARCT | 1 | Strong Buy | $36.00 | N/A | Reiterates | 3 years ago |
Mineralys Therapeutics IncMLYS | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 3 years ago |
Dice Therapeutics IncDICE | 1 | Strong Buy | $65.00 | N/A | Initiates Coverage On | 4 years ago |
Altimmune IncALT | 2 | Strong Buy | $26.00 | N/A | Maintains | 4 years ago |
Albireo Pharma IncALBO | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | 4 years ago |
Invivyd IncIVVD | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Novartis AgNVS | 3 | Hold | N/A | N/A | Downgrades | 6 years ago |
Dermira IncDERM2 | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Tesaro IncTSRO | 4 | Hold | $75.00 | N/A | Downgrades | 8 years ago |
Intra Cellular Therapies IncITCI | 3 | Buy | $27.00 | N/A | Initiates Coverage On | 8 years ago |
Allergan PLCAGN | 3 | Buy | $220.00 | N/A | Initiates Coverage On | 8 years ago |
Celldex Therapeutics IncCLDX | 2 | Hold | $45.00 | N/A | Maintains | 8 years ago |
Astrazeneca PLCAZN | 2 | Hold | $38.00 | N/A | Maintains | 9 years ago |
Pfizer IncPFE | 1 | Hold | $38.00 | N/A | Maintains | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.